151 related articles for article (PubMed ID: 37957199)
1. Impact of the severe familial hypercholesterolemia status on atherosclerotic risks.
Tada H; Nohara A; Usui S; Sakata K; Kawashiri MA; Takamura M
Sci Rep; 2023 Nov; 13(1):19782. PubMed ID: 37957199
[TBL] [Abstract][Full Text] [Related]
2. Substantially Elevated Atherosclerotic Risks in Japanese Severe Familial Hypercholesterolemia Defined by the International Atherosclerosis Society.
Funabashi S; Kataoka Y; Hori M; Ogura M; Nakaoku Y; Nishimura K; Doi T; Nishikawa R; Tsuda K; Noguchi T; Harada-Shiba M
JACC Asia; 2021 Sep; 1(2):245-255. PubMed ID: 36338164
[TBL] [Abstract][Full Text] [Related]
3. Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia.
Tada H; Nomura A; Nohara A; Usui S; Sakata K; Hayashi K; Fujino N; Takamura M; Kawashiri MA
Atherosclerosis; 2023 Apr; 371():61-66. PubMed ID: 36948965
[TBL] [Abstract][Full Text] [Related]
4. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
[TBL] [Abstract][Full Text] [Related]
6. Assessment of coronary atherosclerosis in patients with familial hypercholesterolemia by coronary computed tomography angiography.
Tada H; Kawashiri MA; Okada H; Teramoto R; Konno T; Yoshimuta T; Sakata K; Nohara A; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M; Hayashi K
Am J Cardiol; 2015 Mar; 115(6):724-9. PubMed ID: 25618577
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab.
Ridker PM; Rose LM; Kastelein JJP; Santos RD; Wei C; Revkin J; Yunis C; Tardif JC; Shear CL;
J Clin Lipidol; 2018; 12(4):958-965. PubMed ID: 29685591
[TBL] [Abstract][Full Text] [Related]
8. Familial hypercholesterolemia related admission for acute coronary syndrome in the United States: Incidence, predictors, and outcomes.
Kheiri B; Simpson TF; Osman M; Balla S; Rahmouni H; Mehta A; Pokharel Y; Nasir K; Fazio S; Shapiro MD
J Clin Lipidol; 2021; 15(3):460-465. PubMed ID: 34053910
[TBL] [Abstract][Full Text] [Related]
9. Effect of Cumulative Exposure to Low-Density Lipoprotein-Cholesterol on Cardiovascular Events in Patients With Familial Hypercholesterolemia.
Tada H; Okada H; Nohara A; Yamagishi M; Takamura M; Kawashiri MA
Circ J; 2021 Oct; 85(11):2073-2078. PubMed ID: 34011825
[TBL] [Abstract][Full Text] [Related]
10. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf.
Al-Rasadi K; Al-Zakwani I; Alsheikh-Ali AA; Almahmeed W; Rashed W; Ridha M; Santos RD; Zubaid M
J Clin Lipidol; 2018; 12(3):685-692.e2. PubMed ID: 29574074
[TBL] [Abstract][Full Text] [Related]
12. Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography.
Lee WJ; Chuang HN; Chen YM; Liang KW; Tung H; Chen JP; Lee IT; Wang JS; Lin CH; Lin HJ; Sheu WH; Lee WL; Hsiao TH
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573395
[TBL] [Abstract][Full Text] [Related]
13. Familial hypercholesterolemia and atherosclerotic cardiovascular mortality among Korean adults with low levels of serum cholesterol.
Jung KJ; Koh H; Choi Y; Lee SJ; Ji E; Jee SH
Atherosclerosis; 2018 Nov; 278():103-109. PubMed ID: 30261470
[TBL] [Abstract][Full Text] [Related]
14. Impact of variants of uncertain significance of LDL receptor on phenotypes of familial hypercholesterolemia.
Tada H; Kojima N; Yamagami K; Nomura A; Nohara A; Usui S; Sakata K; Hayashi K; Fujino N; Takamura M; Kawashiri MA
J Clin Lipidol; 2022; 16(6):863-869. PubMed ID: 36229376
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia.
Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
J Clin Lipidol; 2023; 17(3):376-383. PubMed ID: 37003850
[TBL] [Abstract][Full Text] [Related]
16. Genetic mutations, regression of Achilles tendon thickness, and cardiovascular events among patients with familial hypercholesterolemia.
Tada H; Okada H; Nohara A; Takamura M; Kawashiri MA
Atherosclerosis; 2022 Jan; 340():28-34. PubMed ID: 34871818
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
Nanchen D; Gencer B; Auer R; Räber L; Stefanini GG; Klingenberg R; Schmied CM; Cornuz J; Muller O; Vogt P; Jüni P; Matter CM; Windecker S; Lüscher TF; Mach F; Rodondi N
Eur Heart J; 2015 Sep; 36(36):2438-45. PubMed ID: 26142466
[TBL] [Abstract][Full Text] [Related]
18. Familial Hypercholesterolemia Identification Algorithm in Patients with Acute Cardiovascular Events in A Large Hospital Electronic Database in Bulgaria: A Call for Implementation.
Petrov I; Postadzhiyan A; Vasilev D; Kasabov R; Tokmakova M; Nikolov F; Istatkov V; Zhao B; Mutafchiev D; Petkova R
Adv Ther; 2021 May; 38(5):2323-2338. PubMed ID: 33754300
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction.
Rerup SA; Bang LE; Mogensen UM; Engstrøm T; Jørgensen E; Pedersen F; Torp-Pedersen C; Gislason G; James S; Hagström E; Køber L; Fosbøl EL
Am Heart J; 2016 Nov; 181():35-42. PubMed ID: 27823691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
